Pharmaceutical Quality - Chemistry, Manufacturing and Controls (PQ-CMC) Submissions to FDA, published by HL7 International / Biomedical Research and Regulation. This guide is not an authorized publication; it is the continuous build for version 1.1.6 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/FHIR-us-pq-cmc-fda/ and changes regularly. See the Directory of published versions
Generated Narrative: MedicinalProductDefinition d0d2df25-5cfa-4417-b8d1-b8147957f53c
identifier: Oxazepam-Propranolol-BatchFormula-Identification
combinedPharmaceuticalDoseForm: LIQUID
route: ORAL
comprisedOf: Bundle: identifier = UUID:a242b79e-b706-49d3-93ba-b4364ab2baa3; type = document; timestamp = 2024-07-01 12:34:56+0000
name
productName: ATOMOXETINE HYDROCHLORIDE 1mg
type: Non-Proprietary
part
part: ATOMOXETINE HYDROCHLORIDE
type: scientific name
part
part: 1mg
type: ATOMOXETINE HYDROCHLORIDE